Recce Pharmaceuticals Ltd achieves "yet another milestone", receiving ethics approval for Phase I/II diabetic foot ulcer study
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has received approval from the human research ethics committee (HREC) to kick off its Phase I/II clinical...
Source: proactiveinvestors.co.uk